EBRO 2017

Why should we continue to discuss about ART?

- These trials typically represent a paradigm of the time delay-related limitations 1

- Indeed, only 20% of the patients potentially candidate to ART really receive it 2

- Introduction of the PSA dosage and of the concept of early salvage RT (SRT)

1 Arcangeli S et al. Crit Rev Oncol Hematol. 2016 Jan;97:322-7 2 Hoffman Ke et al, J Urol. 2011; 185 (1): 116–120